• About
        • AboutWe challenge convention so healthy can be possible for all
        • Our Story
          • Amneal at-a-glance
          • Our Founders
        • Our Purpose & Commitments
        • Our Milestones
        • Leadership
          • Executive Leadership
          • Board of Directors
        • Locations
        • Responsibility
          • Patient Assistance Programs
          • Product Donations
          • National & Local Philanthropy
          • Compliance and Ethics
        • Awards & Recognition
  • Products
        • ProductsWe produce quality generic, specialty and biosimilar medicines
        • Our Portfolio
          • Generic Products
            • U.S. Generics Catalog
            • Learn About Generics
          • Specialty Products
        • Quality
        • Drug Safety
          • Adverse Event Reporting
          • Medical Inquiries
          • Product Complaints
        • Operations
        • Amneal Products
  • Research & Development
        • Research & DevelopmentWe invest significantly in new product development
        • Generics R&D
        • Specialty R&D
        • Product Partnering
        • Amneal Research and Technology
  • Investors
        • InvestorsBecome an Informed Investor
        • Financial Reports
          • SEC Filings
          • Annual Reports
          • Quarterly & Other Reports
        • Events & Presentations
        • Stock Information
        • Corporate Governance
          • Policies
          • Executive Officers & Directors
          • Board Committees
        • Investor Resources
          • Analysts
          • Investor FAQ
          • Email Alerts
          • Information Request
          • RSS Feeds
        • Amneal Investors
  • News
  • Careers
        • CareersJoin our quest to make healthy possible
        • Total Rewards
        • Search Our Career Opportunities
        • Amneal Careers
  • Contact
  • Customer Login
Amneal Pharmaceuticals

Specialty R&D

We are developing products targeting important medical needs

Our Specialty Pharma business, currently operating as Impax and Gemini, delivers medicines focused on meeting important medical needs across therapeutic categories, including central nervous system disorders, endocrinology, parasitic infections and other therapeutic areas.

We are focused on the continued growth and expansion of our product portfolio through internal development as well as through acquisitions and late-stage and next-generation product partnership opportunities.

Clinical Activities


*As of May 2018

  • Privacy Policy
  • Copyright & Legal Disclaimer
  • Linkedin
© 2018 Amneal Pharmaceuticals LLC.
All rights reserved.